SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-110686
Filing Date
2023-04-21
Accepted
2023-04-21 17:14:57
Documents
13
Period of Report
2023-04-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d473325d8k.htm   iXBRL 8-K 22844
5 GRAPHIC g473325g0421120821209.jpg GRAPHIC 2598
  Complete submission text file 0001193125-23-110686.txt   151775

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230421.xsd EX-101.SCH 2871
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230421_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230421_pre.xml EX-101.PRE 11275
7 EXTRACTED XBRL INSTANCE DOCUMENT d473325d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 23837244
SIC: 2834 Pharmaceutical Preparations